Projekt

RESPECT ESUS: Randomized, double-blind, Evaluation in secondary Stroke Prevention comparing the EfficaCy and safety of the oral Thrombin inhibitor dabigatran etexilate (110 mg or 150 mg, oral b.i.d.) versus acetylsalicylic acid (100 mg oral q.d.) in patients with Embolic Stroke of undetermined Source

Automatisch geschlossen · 2016 bis 2018

Kägi Georg, Vehoff Jochen, Müller Anna, Mbialeu Suzie